Charging Robotics Ltd., a 51%-owned subsidiary of Clearmind Medicine Inc. (NASDAQ: CMND), has launched a wireless electric vehicle charging platform designed for robotaxis, autonomous fleets and automated parking facilities, according to a press release.

The platform uses resonant inductive power transfer technology to deliver electricity across an air gap without physical connectors, eliminating the need for manual cable connections, robotic arms or dedicated docking maneuvers. The system is designed to deliver up to 10 kW of charging power at up to 95% efficiency under specified operating conditions.

For automated parking facilities, the technology allows electric vehicles to charge while stored in areas inaccessible to drivers. For robotaxi and autonomous fleet operations, the platform uses a charging pad and an onboard receiver to initiate and record charging sessions automatically.

The platform includes an AI-driven energy management system that monitors battery levels, vehicle types, onboard charging parameters, expected departure times and charging preferences. The system is designed to allocate power across multiple vehicles, prioritize charging needs and reduce peak electricity demand. Remote monitoring, charging reports and centralized infrastructure management are also supported.

Clearmind Medicine is a clinical-stage biotech company focused on neuroplastogen-derived therapeutics, with Charging Robotics operating as a separate subsidiary.